GMP Certified High Effective Antibiotics Oxytetracycline Capsules 250mg

• Customization: Available
• Application: Internal Medicine
• Usage Mode: For oral administration
• Model NO.: AMC11009
• Suitable for: Elderly, Children, Adult
• State: Solid
• Shape: Capsules
• Type: Organic Chemicals
• Pharmaceutical Technology: Chemical Synthesis
• Transport Package: 12′ S/Box, 10boxes/MID-Box
• Specification: 250mg
• Trademark: Medipharm, OEM
• Origin: China
• HS Code: 3004909099
• Production Capacity: 500000 Boxes/ Month

Product Description

INDICATIONS:
Infections caused by susceptible strains of pathogens:
Upper and lower respiratory tract: Sinusitis pharyngitis, pneumonia and psittacosis Genito-urinary tract; Non-specific urethritis , Iymphogranuloma venereum , chancroid and granuloma inguinale , gonorrhoea, gonococcal salpingitis , epididymitis , acute epididymo-orchitis , endocervical infections and syphillis ( in cases of penicillin allergy).


CONTRA-INDICATIONS:
In patients with renal impairment.
Hypersensitivity to any tetracycline.
Oxytetracycline should not be given in pregnancy, lactation and in young children.

WARNINGS:
Use with care in patients with liver function impairment;
Do not use concomitantly with hepatotoxic medicines;
Tooth discolouration , enamel hypoplasia and retarded bone growth may occur in children under the age of 12 years. These effects may also occur in the foetus if given to prenant women;
Symptoms of myasthenia may be aggravated;
Photosensitivity may occur (see " Side effects and Special Precautions");
Pseudotumor cerebri may occur.

DOSAGE AND DIRECTIONS FOR USE:
Oxytetracycline should be taken either one hour before meals or two hours after meals. The maximum dose for oxytetracyline should not exceed 3g daily for adults and 50mg/kg bodymass/day for children.
The usual dose for oxytetracycline for the commonly occurring infection , depending on the severity is 250 to 500 mg every six hours.
For acne , the adult dosage is as follows: 250mg twice daily

SIDE EFFECTS AND SPECIAL PRECAUTIONS:
Oxytetracycline is not indicated for treating commonly occurring infections in children under 12 years of age.
Gastro-intestinal: Nausea, Vomiting , Diarrhea , Glossitis , Dysphagia related to oesophagitis.
Secondary fungal overgrowth (Candida Albicans): Oral candidiasis, Vulvovaginitis, pruritus ani
Secondary bacterial overgrowth infections may occur.
Resisitant coliform organisms such as Proteus spp. may cause diarrhea.
Supper-infection due to resistant staphylococci may cause fulminating enteritis.
Increased severity of uraemia and hepatotoxicity in patient with renal disease given high doses.

Blood abnormalities: Haemolytic anaemia, Eosinophilia, Neutropenia, 
Thrombocytopenia
Vitamin deficiencies may occur.
Allergic (hypersensitivity) reactions : Urticaria, Maculopapular & Erythematous rashes, Exfoliative dermatitis, Exacerbation of systemic lupus erythematosus pericarditis , henoch-Schonlein purpura (anaphylactoid purpura) , Angioneurotic oedema , Anaphylaxis

Photosensitivity of the skin and nails; onycholysis and nail discolouration may occur.

The use of expired oxytetracycline may lead to the Fanconi-type syndrome which is characterised by polyuria and polydipsia with nausea , vomiting , proteinuria, glucosuria, acidosis and aminoaciduria.

Raised intracranial pressure ( pseudotumor cerebri).

KNOWN SYMPTOMS OF OVERDOSAGE AND PARTICULARS OF ITS TREATMENT:
See "side effects and special precautions". Treatment is symptomatic and supportive.


STORAGE INSTRUCTIONS:
Store in a cool dry place away from light.

KEEP OUT OF REACH OF CHILDREN.
 

More specifications: 

AMC11009-01	Oxytetracycline Caps.	250mg,10*10/BOX
AMC11009-02	Oxytetracycline Caps.	250mg,1000'S/BOTTLE
AMC11009-03	Oxytetracycline Caps.	250mg,12*100/BOX
AMC11009-04	Oxytetracycline Caps.	250mg,12'S/BOX*10/MID BOX